The aim of this project is improve, streamline, and standardize plasmid, viral, and protein-based delivery of CRISPR-Cas components to cells, as well as in vivo. 

Jacob Giehm Mikkelsen (Lentivirus)

Thomas Juhl Corydon (lentivirus and in vivo)

Rasmus O.Bak (RNP)

Lin Lin (AAV and plasmid)

Ernst-Martin Füchtbauer (In vivo)